{
  "resourceType": "Bundle",
  "type": "collection",
  "entry": [
    {
      "resource": {
        "resourceType": "CarePlan",
        "id": "careplan-imaging-recommendations",
        "status": "active",
        "intent": "plan",
        "title": "Imaging Protocol Recommendations",
        "note": [
          {
            "text": "Patient presents with hypotension (MAP 59 mmHg), increasing risk of contrast-induced nephropathy."
          },
          {
            "text": "eGFR of 59 mL/min/1.73m² indicates CKD, warranting renal protective measures."
          },
          {
            "text": "Emergency admission for chest pain necessitates prompt evaluation, but patient safety is paramount."
          },
          {
            "text": "ACR guidelines recommend hydration and risk assessment for contrast media administration in patients with compromised renal function and hemodynamic instability."
          },
          {
            "text": "Carotid CTA protocol is not indicated for the current clinical presentation."
          }
        ],
        "activity": [
          {
            "detail": {
              "kind": "Task",
              "description": "Prioritize hemodynamic stabilization before contrast-enhanced imaging, aiming for MAP > 65 mmHg to mitigate contrast-induced nephropathy risk.",
              "status": "not-started"
            }
          },
          {
            "detail": {
              "kind": "Task",
              "description": "If CT Pulmonary Angiography (CTA PE) is essential, implement pre-hydration with isotonic saline and consider a reduced or split contrast dose protocol with a lower injection rate.",
              "status": "not-started"
            }
          },
          {
            "detail": {
              "kind": "Task",
              "description": "Evaluate the clinical necessity of CTA PE by assessing pre-test probability (e.g., Wells score) and consider alternative imaging modalities like V/Q scan if suspicion is low or contrast administration is contraindicated.",
              "status": "not-started"
            }
          },
          {
            "detail": {
              "kind": "Task",
              "description": "Obtain baseline renal labs immediately prior to contrast administration and plan for post-procedure creatinine monitoring (24-48 hours).",
              "status": "not-started"
            }
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "PlanDefinition",
        "id": "plandefinition-ct-chest-angio-pulmonary-embolism",
        "url": "http://example.org/fhir/PlanDefinition/ct-chest-angio-pulmonary-embolism",
        "version": "1.0",
        "name": "CTChestAngioPulmonaryEmbolism",
        "title": "CT Pulmonary Angiography (Chest CTA for PE)",
        "status": "active",
        "type": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
              "code": "protocol",
              "display": "Protocol"
            }
          ]
        },
        "description": "CT angiography timed for pulmonary arterial phase (6–13 sec post-contrast) to evaluate pulmonary arteries for embolism.",
        "topic": [
          {
            "text": "pulmonary embolism"
          },
          {
            "text": "acute chest pain"
          },
          {
            "text": "shortness of breath"
          }
        ],
        "relatedArtifact": [
          {
            "type": "documentation",
            "url": "http://example.org/fhir/documentation/oaicite-0",
            "display": "Contrast CT phases overview (Wikipedia)"
          },
          {
            "type": "documentation",
            "url": "http://example.org/fhir/documentation/oaicite-1",
            "display": "CT pulmonary angiogram practical notes (Wikipedia)"
          }
        ],
        "action": [
          {
            "title": "Contrast Timing",
            "description": "Pulmonary arterial phase: <6–13 sec post-injection."
          },
          {
            "title": "Contrast Dose",
            "description": "Weight-based; ~100–150 mL iodinated contrast (300 mg I/mL); follow ACR Manual."
          },
          {
            "title": "Renal Safety Notes",
            "description": "Ensure contrast-to-eGFR ratio <1.1 g/(mL/min); if eGFR <30, consider non-contrast alternatives or weigh risks carefully."
          }
        ]
      }
    }
  ]
}